Efficacy of a Conversational AI Agent for Psychiatric Symptoms and Digital Therapeutic Alliance

Does a conversational artificial intelligence (AI)-based platform reduce psychiatric symptoms compared with face-to-face group therapy or a waiting list control?In this randomized clinical trial of 995 university students, the AI intervention was associated with greater reduction in anxiety and improvement in well-being than both comparators, and greater reductions in depression and life satisfaction than the waiting list control; no significant differences were observed for posttraumatic stress disorder symptoms.The findings of this study suggest that conversational AI interventions may represent scalable adjuncts to mental health care.

Corresponding Author: Anat Shoshani, PhD, Baruch Ivcher School of Psychology, Reichman University, PO Box 167, Herzliya 46150, Israel (ashoshani@runi.ac.il).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.